Copyright
©The Author(s) 2022.
World J Gastroenterol. Apr 14, 2022; 28(14): 1479-1493
Published online Apr 14, 2022. doi: 10.3748/wjg.v28.i14.1479
Published online Apr 14, 2022. doi: 10.3748/wjg.v28.i14.1479
Figure 5 Overall survival (OS) curve analysis.
A: The OS curve estimates by clinic-radiological-radiomics model in patients with β-Arrestin1 phosphorylation positive and β-Arrestin1 phosphorylation negative in the training cohort; B: The OS curve estimates by clinic-radiological-radiomics model in patients with β-Arrestin1 phosphorylation positive and β-Arrestin1 phosphorylation negative in the validation cohort.
- Citation: Che F, Xu Q, Li Q, Huang ZX, Yang CW, Wang LY, Wei Y, Shi YJ, Song B. Radiomics signature: A potential biomarker for β-arrestin1 phosphorylation prediction in hepatocellular carcinoma. World J Gastroenterol 2022; 28(14): 1479-1493
- URL: https://www.wjgnet.com/1007-9327/full/v28/i14/1479.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i14.1479